Nanomedicine-Based Combination Anti-Cancer Therapy between Nucleic Acids and Anti-Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatmentof Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti-Cancer Nano Drugs and Nucleic Acid

Abstract

Nanomedicine-based combination anti-cancer therapy between nucleic acids and anti-cancer Nano drugs in covalent Nano drugs delivery systems for selective imaging and treatment of human brain tumors using hyaluronic acid, alguronic acid and sodium hyaluronate (Figures 1 and 2) as anti-cancer Nano drugs and nucleic acids delivery under synchrotron radiation has been explored as an alternative approach to the synthesis of electronically and optically active polymers with several advantages1-33. Horseradish Peroxidase (HRP) catalyzes the decomposition of Hydrogen peroxide (H2O2) at the expense of aromatic proton donors. Horseradish Peroxidase (HRP) is a Fe containing porphyrin-type structure. In previous works, we synthesized hyaluronic acid, alguronic acid and sodium hyaluronate, enzymatically1-33. The results of enzymatic polymerization were different from chemical and electrochemical polymerization of hyaluronic acid, alguronic acid and sodium hyaluronate that reported previously1-33. In this editorial, we reported the enzymatic copolymerization of aniline and hyaluronic acid, alguronic acid and sodium hyaluronate with Horseradish Peroxidase (HRP) in the presence of Sulfonated Polystyrene (SPS) as a template.